BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Cash generated from core business operations
Latest
$-445.91M
↓ 24% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-360.25M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-445.91M | +14.4% |
| 2024 | $-520.73M | +1.3% |
| 2023 | $-527.72M | -25.8% |
| 2022 | $-419.49M | +15.8% |
| 2021 | $-497.93M | -24.6% |
| 2020 | $-399.71M | -57.6% |
| 2019 | $-253.59M | -85.6% |
| 2018 | $-136.64M | -237.5% |
| 2017 | $-40.49M | - |